Clinical Trial Update: A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM) [Phase 3]

View source ↗

Summary

Phase III trial evaluating BL-8040 (motixafortide) with G-CSF versus placebo with G-CSF for mobilizing hematopoietic stem cells in autologous transplantation fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BL-8040
• Filgrastim (filgrastim)

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-11-07